BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37275859)

  • 1. Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy.
    Han J; Wu M; Liu Z
    Front Immunol; 2023; 14():1190333. PubMed ID: 37275859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
    Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
    Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
    Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon: cellular executioner or white knight?
    Maher SG; Romero-Weaver AL; Scarzello AJ; Gamero AM
    Curr Med Chem; 2007; 14(12):1279-89. PubMed ID: 17504213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-induced cell-autonomous immune mechanisms in the control of intracellular protozoa.
    Skariah S; Sultan AA; Mordue DG
    Parasitol Res; 2022 Jun; 121(6):1559-1571. PubMed ID: 35435512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, expression pattern and functional characterization of IFN-γ involved in activating JAK-STAT pathway in Sebastes schlegeli.
    Zhang M; Liu WQ; Wang Y; Yan X; Wang B; Wang GH
    Fish Shellfish Immunol; 2023 Sep; 140():108936. PubMed ID: 37423401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions.
    Li Y; Cui H; Li S; Li X; Guo H; Nandakumar KS; Li Z
    Int Immunopharmacol; 2023 Jan; 114():109585. PubMed ID: 36527884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.
    Mimura K; Teh JL; Okayama H; Shiraishi K; Kua LF; Koh V; Smoot DT; Ashktorab H; Oike T; Suzuki Y; Fazreen Z; Asuncion BR; Shabbir A; Yong WP; So J; Soong R; Kono K
    Cancer Sci; 2018 Jan; 109(1):43-53. PubMed ID: 29034543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania intercepts IFN-γR signaling at multiple levels in macrophages.
    Gurjar D; Kumar Patra S; Bodhale N; Lenka N; Saha B
    Cytokine; 2022 Sep; 157():155956. PubMed ID: 35785668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
    Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
    mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway.
    Ding H; Wang G; Yu Z; Sun H; Wang L
    Biomed Pharmacother; 2022 Nov; 155():113683. PubMed ID: 36095965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
    Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ-induced JAK/STAT, but not NF-κB, signaling pathway is insensitive to glucocorticoid in airway epithelial cells.
    O'Connell D; Bouazza B; Kokalari B; Amrani Y; Khatib A; Ganther JD; Tliba O
    Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(4):L348-59. PubMed ID: 26092996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orf virus inhibits interferon stimulated gene expression and modulates the JAK/STAT signalling pathway.
    Harvey R; McCaughan C; Wise LM; Mercer AA; Fleming SB
    Virus Res; 2015 Oct; 208():180-8. PubMed ID: 26113305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
    Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
    Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
    Dovhey SE; Ghosh NS; Wright KL
    Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway.
    Du Z; Wei L; Murti A; Pfeffer SR; Fan M; Yang CH; Pfeffer LM
    J Cell Biochem; 2007 Dec; 102(5):1087-94. PubMed ID: 17910035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.